Special Feature

User Panel

My Panel

My Panel

Bookmark Science Articles

Recent News
Bookmark / Share This Science Site

Comparison of composite measures of disease activity in an early seropositive rheumatoid arthritis cohort.

Comparison of composite measures of disease activity in an early seropositive rheumatoid arthritis cohort. Research Abstract Details 

Research Abstract Table of Contents

Jump to the:

  • Abstract Text of This Paper
  • Journal Published
  • MeSH Keywords of This Abstract
  • Chemicals and Substances Used in this Paper
  • Grants and Granting Agency of this Research
  • Database Accession Numbers Used in this Paper
  • Related Papers
  • Related Research Tags
  • Rate this Research Paper
  • Comparison of composite measures of disease activity in an early seropositive rheumatoid arthritis cohort. Abstract Text:

    veena k ranganathVeena K Ranganath,jeonglim yoonJeonglim Yoon,dinesh khannaDinesh Khanna,grace s parkGrace S Park,daniel e furstDaniel E Furst,david a elashoffDavid A Elashoff,damini jawaheerDamini Jawaheer,john t sharpJohn T Sharp,richard h goldRichard H Gold,edward c keystoneEdward C Keystone,harold e paulusHarold E Paulus, ,veena k ranganathVeena K Ranganath,jeonglim yoonJeonglim Yoon,dinesh khannaDinesh Khanna,grace s parkGrace S Park,daniel e furstDaniel E Furst,david a elashoffDavid A Elashoff,damini jawaheerDamini Jawaheer,john t sharpJohn T Sharp,richard h goldRichard H Gold,edward c keystoneEdward C Keystone,harold e paulusHarold E Paulus, ,

    OBJECTIVE: To evaluate concordance and agreement of the original DAS44/ESR-4 item composite disease activity status measure with nine simpler derivatives when classifying patient responses by European League of Associations for Rheumatology (EULAR) criteria, using an early rheumatoid factor positive (RF+) rheumatoid arthritis (RA) patient cohort. METHODS: Disease-modifying anti-rheumatic drug-naïve RF+ patients (n = 223; mean duration of symptoms, 6 months) were categorised as ACR none/20/50/70 responders. One-way analysis of variance and two-sample t tests were used to investigate the relationship between the ACR response groups and each composite measure. EULAR reached/change cut-point scores were calculated for each composite measure. EULAR (good/moderate/none) responses for each composite measure and the degree of agreement with the DAS44/ESR-4 item were calculated for 203 patients. RESULTS: Patients were mostly female (78%) with moderate to high disease activity. A centile-based nomogram compared equivalent composite measure scores. Changes from baseline in the composite measures in patients with ACRnone were significantly less than those of ACR20/50/70 responders, and those for ACR50 were significantly different from those for ACR70. EULAR reached/change cut-point scores for our cohort were similar to published cut-points. When compared with the DAS44/ESR-4 item, EULAR (good/moderate/none) percentage agreements were 92 with the DAS44/ESR-3 item, 74 with the Clinical Disease Activity Index, and 80 with the DAS28/ESR-4 item, the DAS28/CRP-4 item and the Simplified Disease Activity Index. CONCLUSION: The relationships of nine different RA composite measures against the DAS44/ESR-4 item when applied to a cohort of seropositive patients with early RA are described. Each of these simplified status and response measures could be useful in assessing patients with RA, but the specific measure selected should be pre-specified and described for each study.

    Comparison of composite measures of disease activity in an early seropositive rheumatoid arthritis cohort. Publishing Authors By Initials

    vk ranganathVK Ranganath,j yoonJ Yoon,d khannaD Khanna,gs parkGS Park,de furstDE Furst,da elashoffDA Elashoff,d jawaheerD Jawaheer,jt sharpJT Sharp,rh goldRH Gold,ec keystoneEC Keystone,he paulusHE Paulus, ,vk ranganathVK Ranganath,j yoonJ Yoon,d khannaD Khanna,gs parkGS Park,de furstDE Furst,da elashoffDA Elashoff,d jawaheerD Jawaheer,jt sharpJT Sharp,rh goldRH Gold,ec keystoneEC Keystone,he paulusHE Paulus, ,

    For similar abstracts research abstracts see: abstracts research

    PUBMED ID PMID:

    MEDLINE DATE:

    Comparison of composite measures of disease activity in an early seropositive rheumatoid arthritis cohort. Journal Published:

    PUBLICATION TYPE: Research Support, Non-U.S. Gov

    Journal: Annals of the rheumatic diseases

    VOLUME: 66

    Page Numbers: 1633-40

    Journal Abbreviation:

    ISSN: 1468-2060

    DAY: 1

    MONTH: 05

    YEAR: 2007

    Comparison of composite measures of disease activity in an early seropositive rheumatoid arthritis cohort. Information

    Number of References:

    LANGUAGE: eng

    NlmUniqueID: 372355

    Comparison of composite measures of disease activity in an early seropositive rheumatoid arthritis cohort. Keywords Mesh Terms:

    KEYWORDS:

    MESH TERMS:

    Chemical & Substance for Abstract: Comparison of composite measures of disease activity in an early seropositive rheumatoid arthritis cohort. Information

    Substance Name:

    Registry Number:

    Grant and Affiliation Information for Comparison of composite measures of disease activity in an early seropositive rheumatoid arthritis cohort.

    AFFILIATION: UCLA, Department of Medicine, Division of Rheumatology, Rehabilitation Center, Room 32-59, 1000 Veteran Avenue, Los Angeles, CA 90095-1670, USA.

    Country: England

    England Research PublicationEngland Research Publication

    AGENCY: United States NIAMS

    GRANT: P60 AR 36834

    ACRONYM: AR

    MEDLINETA: Ann Rheum Dis

    REFSOURCE:

    DATABASENAME:

    ACCESSION NUMBER:

    Number Hits: 0

    Comparison of composite measures of disease activity in an early seropositive rheumatoid arthritis cohort Related Publications

     

    Molecular Station USER Menu

    Welcome to Molecular Station!

    You have to register before you can post on our forums or use our advanced features. Register Now! Its Free and Fast!

    Already registered? Login now below.

    User Name:

    Password:

    Already registered and Forgot your password? Click below to recover it.

    Recover Lost Password

    Join now - it's fast and free!

    Molecular Station is THE largest network of researchers, scientists and science lovers anywhere!

    Research Terms of Usage and Disclaimer
    Home
    Features

    Protocols

    DNA Forum

    Science Forum

    DNA Forum
    Biology Forum

    Science News


    [CaRP] XML error: Invalid document end at line 2

    For more click here:Science News